Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Pelvic Lymph Node Metastases In Prostate Cancer: Preoperative Detection With Dynamic Contrast-enhanced Magnetic Resonance Imaging Compared With Postoperative Pathologic Result Of Pelvic Lymph Node Dissection

J. H. Hwang, Y. Seo, Y. Yu, D. H. Lee, Y. Chung, B. D. Song, T. Kim, Y. J. Lee, J. J. Kim, H. Lee, J. J. Oh, S. Hong, S. Lee, S. Byun, S. Lee
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Received October 20, 2017, Revised October 23, 2017, Accepted October 23, 2017 Corresponding Author: Byeongdo Song Department of Urology, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea E-mail: uromedi@naver.com Tel: +82-31-787-7345, Fax: +82-31-787-4057 ORCID code: https://orcid.org/0000-0003-3961-1258 ᆞThis research was supported by a grant of the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C1264).
This paper references
10.1016/j.juro.2007.11.061
Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
S. Boorjian (2008)
10.1001/JAMA.1997.03540420041027
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
A. Partin (1997)
10.1097/01.JU.0000091805.98960.13
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
I. Cagiannos (2003)
10.1016/j.urolonc.2014.11.008
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
L. Van den Bergh (2015)
10.5489/cuaj.11085
Pre-treatment risk stratification of prostate cancer patients: A critical review.
G. Rodrigues (2012)
10.1200/JCO.1999.17.1.168
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.
A. D'Amico (1999)
10.4111/kju.2012.53.12.830
Usefulness of a Combined Approach of T1-Weighted, T2-Weighted, Dynamic Contrast-Enhanced, and Diffusion-Weighted Imaging in Prostate Cancer
B. D. Min (2012)
10.1016/j.crad.2007.05.022
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.
A. Hövels (2008)
10.6004/JNCCN.2016.0004
Prostate Cancer, Version 1.2016.
J. Mohler (2016)
10.1111/j.1464-410X.2012.11324.x
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011
J. Eifler (2013)
10.4111/kju.2011.52.7.437
Role of Pelvic Lymph Node Dissection in Prostate Cancer Treatment
J. Joung (2011)
10.1016/S0022-5347(01)67620-1
The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.
J. Wolf (1995)
10.1016/j.juro.2013.06.035
Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.
In Gab Jeong (2013)
Cancer statistics , 2017
JY Joung
ESUR prostate MR guidelines 2012
S Yoo
10.1016/S0022-5347(05)67035-8
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
M. Blute (2000)
10.1016/j.eururo.2013.11.002
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
A. Heidenreich (2014)
10.1007/s00330-011-2377-y
ESUR prostate MR guidelines 2012
J. Barentsz (2011)
10.1016/j.juro.2009.08.143
Validation of the partin nomogram for prostate cancer in a national sample.
J. Yu (2010)
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
J. Kirkpatrick (1998)
Prostate cancer, version 2.2014.
J. Mohler (2014)
10.1016/J.UROLOGY.2007.03.042
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
D. Makarov (2007)
Combination of prostate - specific antigen , clinical stage , and Gleason score to predict pathological stage of localized prostate cancer . A multi - institutional update
JB Eifler (1997)
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
O Raz (2013)
10.1016/S0022-5347(05)65172-5
How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
D. Penson (2002)
10.1111/bju.12381
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
J. Thompson (2013)
10.4111/kju.2015.56.7.487
Multiparametric magnetic resonance imaging for prostate cancer: A review and update for urologists
S. Yoo (2015)
10.1038/nrurol.2010.143
MRI for men undergoing active surveillance or with rising PSA and negative biopsies
O. Raz (2010)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
Hodgkin Lymphoma (2014)
10.1016/j.juro.2013.05.032
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
I. Thompson (2013)
10.1016/j.urology.2011.07.1423
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
F. Abdollah (2011)



Semantic Scholar Logo Some data provided by SemanticScholar